GSK’s paediatric pneumococcal candidate vaccine Synflorix™ receives positive opinion in Europe
17y agoen
From the article
Serotypes included in the vaccine are responsible for up to 90% of invasive pneumoccal disease in young children in Europe. 1,2,3
Continue reading on GSKYou might also wanna read
Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe
doi.org·17d ago

Pneumococcal membrane particles show promise for serotype-independent vaccine protection against Streptococcus pneumoniae colonization
This scientific research article presents a study on pneumococcal membrane particles as a potential vaccine strategy against Streptococcus p
FDA advisory panel recommends updating fall Covid vaccines to target XFG variant
An FDA advisory panel recommended updating fall 2025 Covid-19 vaccines to target the XFG variant ("stratus"), a fast-growing strain. The rec

Crianças curadas da leucemia podem precisar tomar todas as vacinas novamente; estudo explica por quê
Correio 24h·3y ago
Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine
Medscape·1d ago

Catalonia plays in the European research Champions League
Ara·3d ago

Catalonia plays in the European research Champions League
Ara·3d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.